Cellular and molecular basis of RV hypertrophy in congenital heart disease
Authors:
Open Access
Abstract
RV hypertrophy (RVH) is one of the triggers of RV failure in congenital heart disease (CHD). Therefore, improving our understanding of the cellular and molecular basis of this pathology will help in developing strategic therapeutic interventions to enhance patient benefit in the future. This review describes the potential mechanisms that underlie the transition from RVH to RV failure. In particular, it addresses structural and functional remodelling that encompass contractile dysfunction, metabolic changes, shifts in gene expression and extracellular matrix remodelling. Both ischaemic stress and reactive oxygen species production are implicated in triggering these changes and will be discussed. Finally, RV remodelling in response to various CHDs as well as the potential role of biomarkers will be addressed.Keywords
This publication has 30 references indexed in Scilit:
- The Right Ventricle in Pulmonary Arterial HypertensionCirculation Research, 2014
- Right Versus Left Ventricular FailureCirculation, 2014
- A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertensionJournal of Molecular Medicine, 2013
- Right Ventricle: Wrong Targets?Circulation, 2013
- Right Ventricular Failure and Pathobiology in Patients with Congenital Heart Disease – Implications for Long-Term Follow-UpFrontiers in Pediatrics, 2013
- FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetateJournal of Molecular Medicine, 2012
- Mortality with congenital heart defects in England and Wales, 1959–2009: exploring technological change through period and birth cohort analysisArchives of Disease in Childhood, 2012
- Mitochondrial metabolic adaptation in right ventricular hypertrophy and failureJournal of Molecular Medicine, 2010
- Congenital heart disease in relation to pulmonary hypertension in paediatric practicePaediatric Respiratory Reviews, 2005
- Increased [18F]Fluorodeoxyglucose Accumulation in Right Ventricular Free Wall in Patients With Pulmonary Hypertension and the Effect of EpoprostenolJACC, 2005